CDX2 is Not of Prognostic Significance In Mismatch Repair Deficient Colorectal Cancer

被引：0
|
作者：
Geraghty, Robert
Ryan, Eanna [1 ]
Creavin, Ben [1 ]
Khaw, Yi Ling
Gibbons, David [2 ]
Ryan, Elizabeth [3 ]
O'Connell, Ronan [4 ]
Martin, Sean [4 ]
Kennelly, Rory [4 ]
Winter, Des [1 ]
Sheahan, Kieran [5 ]
机构：
[1] St Vincents Univ Hosp, Dublin, Ireland
[2] St Lukes Hosp, Dublin, Ireland
[3] Ctr Colorectal Dis, Dublin, Ireland
[4] St Vincents Univ Hosp, Ctr Colorectal Dis, Elm Pk, Dublin, Ireland
[5] St Vincent Hosp, Dublin, Ireland
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
734
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [1] CDX2 is Not of Prognostic Significance In Mismatch Repair Deficient Colorectal Cancer
    Geraghty, Robert
    Ryan, Eanna
    Creavin, Ben
    Khaw, Yi Ling
    Gibbons, David
    Ryan, Elizabeth
    O'Connell, Ronan
    Martin, Sean
    Kennelly, Rory
    Winter, Des
    Sheahan, Kieran
    LABORATORY INVESTIGATION, 2018, 98 : 264 - 264
  • [2] CDX2 as a prognostic biomarker in stage II and stage III mismatch repair deficient colorectal cancer
    Ryan, E.
    Khaw, Y. L.
    Creavin, B.
    Geraghty, R.
    Gibbons, D.
    Sheahan, K.
    O'Connell, P. R.
    Winter, D. C.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 44 - 44
  • [3] Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancer
    Ryan, E. J.
    Creavin, B.
    Khaw, Y. L.
    Kelly, M. E.
    Mohan, H. M.
    Geraghty, R.
    Ryann, E. J.
    Kennelly, R.
    Hanly, A.
    Martin, S. T.
    Fennelly, D.
    McDermott, R.
    Gibbons, D.
    O'Connell, P. R.
    Sheahan, K.
    Winter, D. C.
    BJS OPEN, 2018, 2 (06): : 456 - 463
  • [4] SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer
    Ma, Changqing
    Olevian, Dane
    Miller, Caitlyn
    Herbst, Cameron
    Jayachandran, Priya
    Kozak, Margaret M.
    Chang, Daniel T.
    Pai, Reetesh K.
    MODERN PATHOLOGY, 2019, 32 (08) : 1217 - 1231
  • [5] Prognostic impact of CDX2 in colorectal cancer
    Yuan, Lan-Ting Emily
    Ting, Kai-Ting
    Huang, Chih-Wei Dave
    Tsai, Ching-Yang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 518 - 518
  • [6] Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer
    Vlahovic, Ivan
    Rajc, Jasmina
    Svagelj, Ivan
    Solic, Kresimir
    Svagelj, Drazen
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [7] CDX2 immunohistochemistry as a prognostic biomarker for colorectal cancer
    Fatimilehin, A.
    Mikropoulos, C.
    Summers, J.
    Rajakumar, L.
    Hill, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer
    Chan, Wei Yen
    Chua, Wei
    Wilkinson, Kate
    Epitakaduwa, Chandika
    Mandaliya, Hiren
    Descallar, Joseph
    Roberts, Tara Laurine
    Becker, Therese Maria
    Ng, Weng
    Lee, Cheok Soon
    Lim, Stephanie Hui-Su
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [9] The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer
    Jens Neumann
    Volker Heinemann
    Jutta Engel
    Thomas Kirchner
    Sebastian Stintzing
    Virchows Archiv, 2018, 473 : 199 - 207
  • [10] The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer
    Neumann, Jens
    Heinemann, Volker
    Engel, Jutta
    Kirchner, Thomas
    Stintzing, Sebastian
    VIRCHOWS ARCHIV, 2018, 473 (02) : 199 - 207
12345